-
Trevi Therapeutics (NASDAQ:TRVI) Given New $20.00 Price Target at Oppenheimer
Source: Buzz FX / 12 Mar 2025 09:42:17 America/Chicago
Trevi Therapeutics (NASDAQ:TRVI) Given New $20.00 Price Target at Oppenheimer Written by MarketBeat March 12, 2025 Share Link copied to clipboard. Remove Ads Trevi Therapeutics ( NASDAQ:TRVI - Get Free Report ) had its price objective incre
Read more...